rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
25	Lymphoproliferative disorder	C0024314	20	236	1.49392720417e-11	9.593246354566385e-06	IGHV4-34,IGKV3-15,BTK,FCGR3A,LAT,PIK3CB,IL2RB,IGKV3-20,IL2RA,JAK3,IGLV3-21,JAK1,IGHV2-5,IL2,IGHV1-69,PIK3CA,KLRK1,SYK,IGKV1-5,LCK
26	Autoimmune disease 1	C0004364	25	890	4.18310941441e-11	9.976976208749041e-06	FCGR1A,IL2RG,PLCG2,SOS1,BTK,HLA-E,FCGR3A,PIK3CB,IL2RB,ELMO1,IL2RA,FCGR2A,JAK3,CD3G,IGHG3,JAK1,TYROBP,IL2,PIK3CA,CD247,KLRK1,KLRD1,B2M,GRAP2,LCK
27	Hairy Cell Leukemia	C0023443	11	110	4.95999907812e-11	1.0360706062931696e-05	IGHV4-34,BTK,PIK3CB,IL2RB,IL2RA,IGHV3-33,IGHV3-30,IGHV2-5,IL2,PIK3CA,GRAP2
28	Idiopathic thrombocytopenic purpura	C0398650	10	111	5.97144556025e-11	1.0744435917114352e-05	FCGR1A,HLA-E,FCGR3A,IL2RA,FCGR2A,IGHG1,JAK1,IGHV2-5,IL2,IGKC
29	Chronic Lymphocytic Leukemia	C0023434	39	1176	6.59964305427e-11	1.1128165771297006e-05	IGHV4-34,IL2RG,PLCG2,IGHM,BTK,HLA-E,IGHV3-23,IGHD,IGHV1-2,FCGR3A,PIK3CB,IGHV3-53,IGKV3-20,IL2RA,FCGR2A,JAK3,IGHG3,IGLV3-21,IGKV2-30,IGHG1,JAK1,IGHV2-5,FN1,IGLV1-44,IL2,IGHV1-69,PIK3CA,CD247,KLRK1,IGHV3-11,SYK,IGKV1-5,B2M,GRAP2,LYN,RAC1,LCK,IGKV1-39,IGHV4-39
30	Immunodeficiency due to defect in CD3-gamma	C0021051	19	571	8.60257420854e-11	1.1511895625479662e-05	IL2RG,PLCG2,IGHM,BTK,HLA-E,FCGR3A,LAT,PIK3CB,IL2RB,IL2RA,JAK3,CD3G,FN1,IL2,PIK3CA,CD247,KLRK1,PIK3R1,LCK
31	Multiple Myeloma	C0026764	26	1236	4.28524771223e-10	1.1895625479662319e-05	IGHV4-34,FCGR1A,SOS1,IGHM,BTK,HLA-E,FCGR3A,PIK3CB,IL2RB,IGKV3-20,IL2RA,FCGR2A,JAK3,IGHG3,JAK1,IGHV2-5,FN1,GRB2,IL2,PIK3CA,KLRK1,PIK3R2,PIK3R1,IGKV1-5,B2M,GRAP2
32	Lymphoma, Large B-Cell, Diffuse	C0024299	27	1362	7.25829396586e-10	1.2279355333844973e-05	FCGR1A,IL2RG,PLCG2,SOS1,BTK,HLA-E,FCGR3A,PIK3CB,IL2RA,FCGR2A,JAK3,CD3G,JAK1,IGHV2-5,FN1,IL2,PIK3CA,KLRK1,KLRD1,SYK,IGKV1-5,B2M,GRAP2,LYN,RAC1,IGLV6-57,LCK
33	Lupus Erythematosus, Systemic	C0024141	28	1467	8.34205149403e-10	1.266308518802763e-05	FCGR1A,SOS1,IGHM,HLA-E,FCGR3A,LAT,PIK3CB,IL2RB,IGKV3-20,IL2RA,FCGR2A,IGHG3,JAK1,IGHV2-5,FN1,TYROBP,IL2,PIK3CA,CD247,FYN,KLRK1,KLRC2,KLRD1,SYK,B2M,LYN,IGHV3-7,LCK
34	Symptomatic human immunodeficiency virus infection	C0019693	32	1900	1.17158194257e-09	1.3046815042210284e-05	FCGR1A,IL2RG,PLCG2,PLCG1,BTK,HLA-E,FCGR3A,LAT,PIK3CB,IL2RB,IL2RA,FCGR2A,CD3G,IGHG3,SHC1,JAK1,IGHV2-5,FN1,GRB2,IL2,PIK3CA,CD247,FYN,KLRK1,KLRC2,PIK3R1,KLRD1,B2M,GRAP2,LYN,RAC1,LCK
35	Lymphopenia	C0024312	9	122	1.20231580247e-09	1.343054489639294e-05	IL2RG,IGHM,HLA-E,FCGR3A,IL2RA,JAK3,CD3G,IL2,CD247
36	Decreased antibody level in blood	C4048270	8	91	1.47530054839e-09	1.3814274750575595e-05	IL2RG,PLCG2,IGHM,BTK,IL2RA,JAK3,PIK3R1,B2M
37	Waldenstrom macroglobulinemia	C0024419	8	96	2.44035236463e-09	1.419800460475825e-05	IGHV4-34,BTK,FCGR3A,PIK3CB,IL2RA,IGHV2-5,PIK3CA,SYK
38	Abnormal immunoglobulin level	C1855755	9	134	2.8745508196e-09	1.4581734458940905e-05	IL2RG,PLCG2,IGHM,BTK,IL2RA,JAK3,PIK3R1,B2M,IGKC
39	Abnormality of B cells	C4021748	9	136	3.34119520939e-09	1.4965464313123562e-05	IL2RG,PLCG2,IGHM,BTK,IL2RA,JAK3,PIK3R1,B2M,IGKC
40	Abnormality of B cell physiology	C1849242	9	136	3.34119520939e-09	1.5349194167306218e-05	IL2RG,PLCG2,IGHM,BTK,IL2RA,JAK3,PIK3R1,B2M,IGKC
41	Choreoacanthocytosis	C0393576	5	28	7.25379256661e-09	1.5732924021488872e-05	PIK3CB,PIK3CA,PIK3R2,PIK3R1,RAC1
42	Splenic Marginal Zone B-Cell Lymphoma	C0349632	6	49	7.68314634136e-09	1.6116653875671527e-05	IGHV1-2,IL2RA,IGHV2-5,IL2,IGHV1-69,IGHV4-39
43	Abnormality of lymphocytes	C0427546	10	194	8.29075752495e-09	1.650038372985418e-05	IL2RG,PLCG2,IGHM,BTK,IL2RA,JAK3,CD247,PIK3R1,B2M,IGKC
44	Meningitis	C0497299	8	116	1.30103431362e-08	1.688411358403684e-05	FCGR1A,IGHM,BTK,FCGR3A,FCGR2A,JAK3,FN1,PIK3R1
45	Abnormality of humoral immunity	C3150510	9	157	1.32827024935e-08	1.7267843438219494e-05	IL2RG,PLCG2,IGHM,BTK,IL2RA,JAK3,PIK3R1,B2M,IGKC
46	Leukemia, Large Granular Lymphocytic	C1522378	6	54	1.54708355016e-08	1.7651573292402148e-05	FCGR3A,IL2RB,IL2RA,TYROBP,IL2,KLRK1
47	Peripheral T-Cell Lymphoma	C0079774	8	122	2.02380189274e-08	1.8035303146584806e-05	VAV3,PIK3CB,IL2RB,PIK3CA,FYN,SYK,B2M,GRAP2
48	Tropical Spastic Paraparesis	C0030481	6	58	2.5781600077e-08	1.841903300076746e-05	IL2RG,HLA-E,IL2RB,IL2RA,IL2,B2M
49	Classical Hodgkin's Lymphoma	C1333064	8	126	2.67844773028e-08	1.8802762854950115e-05	HLA-E,PIK3CB,IL2,PIK3CA,SYK,B2M,GRAP2,LCK
51	Common variable immunodeficiency 2	C0009447	8	130	3.52002192949e-08	1.9570222563315427e-05	BTK,HLA-E,FCGR3A,IL2RA,FCGR2A,IGHG3,IGHV2-5,IL2
52	Allergic rhinitis	C2607914	9	174	3.54074373154e-08	1.9953952417498082e-05	FCGR1A,PLCG2,FCGR3A,PIK3CB,IL2RB,IL2RA,FN1,IL2,PIK3CA
53	Adult T-Cell Lymphoma/Leukemia	C0023493	14	469	3.54451552553e-08	2.0337682271680737e-05	IL2RG,PLCG1,HLA-E,PIK3CB,IL2RB,IL2RA,JAK3,JAK1,FN1,IL2,PIK3CA,FYN,B2M,LCK
54	Respiratory tract infection	C0035243	13	404	3.87312980576e-08	2.072141212586339e-05	FCGR1A,IL2RG,PLCG2,IGHM,BTK,FCGR3A,IL2RA,FCGR2A,JAK3,CD3G,IL2,PIK3R1,LCK
55	Abnormality of cellular immune system	C4023612	13	406	4.11659677457e-08	2.110514198004605e-05	IL2RG,PLCG2,IGHM,BTK,IL2RA,JAK3,TYROBP,PIK3CA,CD247,PIK3R1,TREM2,B2M,IGKC
56	Abnormal leukocyte count	C0152009	13	406	4.11659677457e-08	2.1488871834228703e-05	IL2RG,PLCG2,IGHM,BTK,IL2RA,JAK3,TYROBP,PIK3CA,CD247,PIK3R1,TREM2,B2M,IGKC
57	Leukemia, T-cell acute lymphoblastoid (2)	C0023492	12	348	5.08445701097e-08	2.1872601688411358e-05	IL2RG,HLA-E,FCGR3A,PIK3CB,IL2RB,IL2RA,JAK3,IL2,PIK3CA,LYN,RAC1,LCK
59	Polymyositis	C0085655	7	102	7.86250666795e-08	2.264006139677667e-05	SOS1,HLA-E,IGHG2,IL2RA,IGHG1,IL2,IGKC
60	B-cell lymphoma	C0079731	16	652	8.00575180593e-08	2.3023791250959325e-05	VAV3,BTK,HLA-E,IGHV3-23,FCGR3A,PIK3CB,IL2RA,FCGR2A,IGHV2-5,FN1,IL2,PIK3CA,SYK,B2M,GRAP2,LYN
61	Lymphocytosis	C0024282	6	69	8.81333164227e-08	2.340752110514198e-05	IGHV3-23,IGHV1-2,FCGR3A,IGHV2-5,IL2,KLRK1
62	Rheumatoid arthritis	C0003873	28	1856	1.40065378296e-07	2.3791250959324637e-05	FCGR1A,IL2RG,SOS1,HLA-E,FCGR3A,PIK3CB,IL2RB,IGKV3-20,IL2RA,FCGR2A,JAK3,CD3G,IGHG3,JAK1,IGHV2-5,FN1,TYROBP,IL2,IGHV1-69,CLEC6A,PIK3CA,CD247,KLRK1,KLRC2,KLRD1,B2M,IGKC,GRAP2
67	Juvenile myelomonocytic leukemia	C0349639	7	116	2.13906699131e-07	2.5709900230237913e-05	IL2RG,SOS1,PIK3CB,JAK3,PIK3CA,PIK3R2,PIK3R1
68	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	28	1913	2.64586745402e-07	2.6093630084420568e-05	IL2RG,PLCG1,SOS1,BTK,HLA-E,PIK3CB,IL2RB,IL2RA,JAK3,IGHE,CD3G,JAK1,IGHV2-5,FN1,TYROBP,GRB2,IL2,IGHV1-69,PIK3CA,KLRK1,PIK3R1,SYK,TREM2,B2M,GRAP2,LYN,RAC1,LCK
69	Guillain-Barre syndrome, familial	C0018378	5	52	3.49683769274e-07	2.6477359938603222e-05	FCGR1A,FCGR3A,IL2RA,FCGR2A,IL2
70	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	14	568	4.16607425668e-07	2.686108979278588e-05	IGHV4-34,FCGR1A,SOS1,BTK,HLA-E,FCGR3A,PIK3CB,FCGR2A,JAK3,IGHV2-5,IL2,PIK3CA,SYK,B2M
71	Recurrent viral infections	C1837066	4	29	4.36616381494e-07	2.7244819646968535e-05	IGHM,BTK,IL2RA,CD247
72	Thymoma	C0040100	8	176	4.7059014241e-07	2.762854950115119e-05	HLA-E,PIK3CB,IL2RA,FCGR2A,IL2,PIK3CA,CD247,LCK
73	T-Cell Prolymphocytic Leukemia	C0023494	4	30	5.21693677591e-07	2.8012279355333844e-05	IL2RA,JAK3,JAK1,IL2
74	Increased inflammatory response	C4022803	14	581	5.53915409651e-07	2.83960092095165e-05	IL2RG,PLCG2,IGHM,BTK,FCGR3A,IL2RB,IL2RA,JAK3,CD3G,PIK3CA,CD247,PIK3R1,B2M,LCK
75	Abnormal inflammatory response	C4022805	14	581	5.53915409651e-07	2.8779739063699156e-05	IL2RG,PLCG2,IGHM,BTK,FCGR3A,IL2RB,IL2RA,JAK3,CD3G,PIK3CA,CD247,PIK3R1,B2M,LCK
80	Asthma	C0004096	23	1454	7.70951067874e-07	3.0698388334612435e-05	FCGR1A,VAV3,IL2RG,PLCG2,HLA-E,FCGR3A,IGHG2,LAT,PIK3CB,IL2RB,IL2RA,FCGR2A,JAK3,IGHE,IGHG3,IGHG1,JAK1,IGHV2-5,FN1,IL2,PIK3CA,FYN,PIK3R1
81	X-linked agammaglobulinemia	C0221026	5	60	8.3032671172e-07	3.108211818879509e-05	BTK,HLA-E,FCGR3A,IGHV2-5,PIK3R1
82	Sepsis	C0243026	14	602	8.63523950345e-07	3.1465848042977744e-05	FCGR1A,IL2RG,IGHM,BTK,FCGR3A,PIK3CB,IL2RA,FCGR2A,FN1,IL2,PIK3CA,FYN,PIK3R1,GRAP2
85	Myeloid leukemia	C0023470	13	533	1.1038083676e-06	3.261703760552571e-05	SOS1,HLA-E,PIK3CB,LAT2,IL2RB,IL2RA,JAK3,JAK1,FN1,IL2,PIK3CA,KLRK1,RAC1
86	Hematological neoplasm	C0376545	14	615	1.12602579516e-06	3.300076745970836e-05	IL2RG,BTK,PIK3CB,IGKV3-20,FCGR2A,JAK3,JAK1,TYROBP,IL2,PIK3CA,KLRK1,SYK,TREM2,B2M
87	B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	C1292769	11	385	1.15867930406e-06	3.338449731389103e-05	IL2RG,IGHM,BTK,HLA-E,IL2RA,JAK3,IGHV2-5,IL2,IGHV3-11,LCP2,SYK
88	X-linked severe combined immunodeficiency	C1279481	4	35	1.16318514443e-06	3.376822716807368e-05	IL2RG,JAK3,JAK1,IL2
89	Graft-versus-host disease, susceptibility to	C0018133	10	317	1.168639303e-06	3.4151957022256336e-05	IL2RG,HLA-E,FCGR3A,IL2RA,FCGR2A,JAK3,FN1,IL2,KLRK1,KLRD1
90	Arthropathy	C0022408	7	147	1.30541294507e-06	3.453568687643899e-05	HLA-E,IL2RB,IL2RA,IL2,CD247,B2M,GRAP2
91	Severe combined immunodeficiency due to ADA deficiency	C0085110	13	545	1.43324599755e-06	3.4919416730621645e-05	IL2RG,BTK,HLA-E,FCGR3A,IL2RB,IL2RA,JAK3,CD3G,FN1,IL2,SYK,B2M,LCK
92	{Systemic lupus erythematosus, susceptibility to, 8} (2)	C0409974	11	393	1.43533874319e-06	3.5303146584804296e-05	FCGR1A,HLA-E,FCGR3A,IL2RA,FCGR2A,IGHG3,IGHV2-5,IL2,CD247,KLRC2,KLRD1
98	Autoimmune hemolytic anemia	C0002880	4	37	1.54845588229e-06	3.760552570990023e-05	FCGR3A,IL2RA,CD3G,IGHV2-5
99	Pneumonia	C0032285	12	471	1.58110731197e-06	3.798925556408289e-05	FCGR1A,IL2RG,IGHM,BTK,FCGR3A,IL2RB,FCGR2A,JAK3,FN1,IL2,CLEC6A,SYK
100	Hepatitis C	C0019196	15	721	1.65866943802e-06	3.837298541826554e-05	SOS1,HLA-E,FCGR3A,PIK3CB,IL2RB,JAK1,IGHV2-5,FN1,GRB2,IL2,PIK3CA,KLRK1,KLRD1,GRAP2,LCK
102	Combined immunodeficiency, X-linked	C0494261	4	38	1.77540682444e-06	3.9140445126630855e-05	IL2RG,HLA-E,JAK3,B2M
103	Polyarticular arthritis	C0162323	4	38	1.77540682444e-06	3.952417498081351e-05	HLA-E,IL2RB,IL2RA,CD247
104	Inflammatory abnormality of the eye	C4020969	7	155	1.94412313703e-06	3.9907904834996164e-05	IGHM,BTK,IL2RB,IL2RA,CD247,PIK3R1,B2M
105	Myasthenia Gravis	C0026896	8	209	1.96926763174e-06	4.029163468917882e-05	FCGR1A,HLA-E,FCGR3A,IL2RB,IL2RA,FCGR2A,IL2,GRAP2
106	Chronic myeloid leukemia	C0023473	16	822	1.99588899341e-06	4.067536454336147e-05	SOS1,HLA-E,FCGR3A,PIK3CB,IL2RA,JAK3,FN1,GRB2,IL2,PIK3CA,CD247,SYK,B2M,GRAP2,LYN,RAC1
107	Chronic diarrhea	C0401151	4	39	2.02780607406e-06	4.105909439754413e-05	IL2RG,BTK,IL2RA,B2M
108	Agammaglobulinemia 8, autosomal dominant	C0001768	4	40	2.30748018482e-06	4.144282425172678e-05	IL2RG,IGHM,BTK,PIK3R1
109	{Pemphigoid, susceptibility to} (2)	C0030805	5	72	2.45844574509e-06	4.182655410590945e-05	HLA-E,FCGR3A,IL2RA,FCGR2A,IGHE
110	Diffuse Scleroderma	C1258104	4	41	2.61679679248e-06	4.22102839600921e-05	HLA-E,FCGR3A,FCGR2A,FN1
111	Inflammatory abnormality of the skin	C3875321	9	278	2.64635789204e-06	4.2594013814274756e-05	IL2RG,IGHM,BTK,ELMO1,IL2RA,CD3G,PIK3CA,PIK3R1,B2M
113	Multiple Sclerosis	C0026769	19	1140	2.91008014397e-06	4.3361473522640065e-05	FCGR1A,PLCG1,HLA-E,FCGR3A,IL2RB,IL2RA,FCGR2A,JAK1,FN1,IL2,KLRK1,KLRC2,KLRD1,SYK,TREM2,B2M,GRAP2,VAV2,IGHV4-39
114	Dermatomyositis	C0011633	6	115	2.91645894923e-06	4.3745203376822716e-05	HLA-E,IGHG2,IL2RA,IGHG1,IL2,IGKC
118	Osteomyelitis, sterile multifocal, with periostitis and pustulosis	C0029443	5	75	3.12707653161e-06	4.528012279355334e-05	IGHM,BTK,HLA-E,FN1,PIK3R1
119	Paroxysmal nocturnal hemoglobinuria	C0024790	5	75	3.12707653161e-06	4.5663852647736e-05	FCGR1A,HLA-E,FCGR3A,IL2,KLRK1
120	Cellulitis	C0007642	4	43	3.3324389167e-06	4.604758250191865e-05	PLCG2,IGHM,BTK,PIK3R1
122	Lupus Nephritis	C0024143	8	226	3.73701935941e-06	4.681504221028396e-05	FCGR1A,HLA-E,FCGR3A,FCGR2A,IGHG3,FN1,IL2,CLEC4E
123	Cytomegalovirus Infections	C0010823	7	174	4.59607396175e-06	4.719877206446662e-05	HLA-E,IL2,KLRK1,KLRC2,KLRD1,B2M,GRAP2
124	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	C0239998	12	521	4.75585413184e-06	4.7582501918649275e-05	IL2RG,PLCG2,IGHM,BTK,FCGR3A,IL2RA,JAK3,CD3G,CD247,PIK3R1,IGKC,LCK
125	Acute myeloid leukemia	C0023467	24	1733	4.94663259742e-06	4.796623177283193e-05	FCGR1A,PLCG1,SOS1,BTK,HLA-E,FCGR3A,PIK3CB,LAT2,IL2RB,IL2RA,FCGR2A,JAK3,CD3G,JAK1,FN1,IL2,PIK3CA,KLRK1,KLRD1,SYK,B2M,GRAP2,LYN,RAC1
126	Chronic Chagas' disease	C0041234	7	176	5.00063021802e-06	4.8349961627014584e-05	HLA-E,PIK3CB,IL2RB,IL2RA,IGHV2-5,IL2,PIK3CA
133	T-cell lymphoma	C0079772	9	302	5.50727533666e-06	5.1036070606293175e-05	IL2RG,SOS1,IL2RB,IL2RA,JAK3,JAK1,IL2,KLRK1,SYK
134	Anterior uveitis	C0042165	4	48	5.8020765823e-06	5.1419800460475826e-05	IL2RB,IL2RA,IL2,CD247
135	Papillary thyroid carcinoma	C0238463	11	451	5.88625002595e-06	5.1803530314658484e-05	SOS1,HLA-E,FCGR3A,PIK3CB,IL2RA,IGHG1,FN1,IL2,PIK3CA,B2M,GRAP2
136	CNS infection	C0007684	5	84	6.06869908526e-06	5.2187260168841135e-05	IL2RG,IGHM,BTK,JAK3,PIK3R1
137	Giant cell arteritis	C0039483	6	129	6.2526857052e-06	5.257099002302379e-05	HLA-E,FCGR3A,IL2RA,FCGR2A,IL2,KLRK1
138	Tumor Initiation	C0598935	7	182	6.4001667851e-06	5.2954719877206445e-05	SOS1,PIK3CB,FN1,PIK3CA,KLRK1,GRAP2,RAC1
139	Diarrhea 8, secretory sodium, congenital	C0011991	10	379	6.48390305247e-06	5.333844973138911e-05	IL2RG,IGHM,BTK,IL2RA,JAK3,CD247,PIK3R1,B2M,IGKC,LCK
140	Dental malocclusion	C0024636	5	85	6.50110103961e-06	5.372217958557176e-05	SOS1,IL2RB,IL2RA,CD247,PIK3R1
141	Abnormality of the paranasal sinuses	C4025873	5	86	6.9581700981e-06	5.410590943975442e-05	IL2RG,IGHM,BTK,FCGR3A,PIK3R1
142	Myeloproliferative Disorders	C0027022	8	245	7.18521459098e-06	5.448963929393707e-05	PIK3CB,IL2RB,JAK3,JAK1,FN1,PIK3CA,SYK,RAC1
143	Gingival Diseases	C0017563	6	132	7.27514408094e-06	5.487336914811973e-05	HLA-E,FCGR3A,IL2RA,FCGR2A,FN1,IL2
144	Abnormality of cell physiology	C4023595	9	313	7.53489546612e-06	5.525709900230238e-05	IL2RG,PLCG2,IGHM,BTK,IL2RA,JAK3,PIK3R1,B2M,IGKC
149	Recurrent respiratory infections	C3806482	9	318	8.65183658161e-06	5.717574827321566e-05	IL2RG,IGHM,BTK,FCGR3A,IL2RA,JAK3,CD3G,PIK3R1,LCK
150	Juvenile rheumatoid arthritis	C3714757	7	190	8.77018384693e-06	5.755947812739831e-05	HLA-E,FCGR3A,IL2RB,IL2RA,IGHG3,IL2,CD247
151	Myositis	C0027121	6	136	8.85114240701e-06	5.794320798158097e-05	HLA-E,FCGR3A,IGHG2,IGHG1,KLRK1,IGKC
152	Discoid lupus erythematosus	C0024138	9	319	8.891630907e-06	5.832693783576362e-05	HLA-E,FCGR3A,IL2RA,FCGR2A,CD3G,IGHG3,IGHV2-5,IL2,CD247
153	Periodontitis, Juvenile	C0031106	5	90	9.0547083097e-06	5.871066768994628e-05	FCGR1A,HLA-E,FCGR3A,FCGR2A,IL2
154	Latent autoimmune diabetes mellitus in adult	C0205734	5	90	9.0547083097e-06	5.909439754412894e-05	FCGR1A,HLA-E,IL2RA,IL2,B2M
155	Elevated C-reactive protein level	C4023452	3	25	9.09489022027e-06	5.9478127398311595e-05	IL2RB,IL2RA,CD247
156	Urticaria Pigmentosa	C0042111	4	53	9.51747564248e-06	5.9861857252494246e-05	PIK3CB,IL2RA,IGHE,PIK3CA
157	Rhinitis, Allergic, Seasonal	C0035455	6	138	9.7394774401e-06	6.0245587106676904e-05	PLCG2,IL2RA,FCGR2A,IGHE,IGHG3,FN1
158	Cutaneous T-cell lymphoma	C0079773	8	255	9.90476675033e-06	6.0629316960859555e-05	PLCG1,PIK3CB,IL2RA,JAK3,JAK1,IL2,PIK3CA,KLRK1
159	Recurrent bacterial infection	C0004623	8	255	9.90476675033e-06	6.101304681504221e-05	FCGR1A,BTK,HLA-E,FCGR2A,JAK3,IGHG3,KLRK1,TREM2
160	Congenital short bowel syndrome	C0021847	3	26	1.07039419477e-05	6.139677666922487e-05	SOS1,PIK3CB,PIK3CA
161	Autoimmune antibody positivity	C4022660	3	26	1.07039419477e-05	6.178050652340752e-05	IL2RB,IL2RA,CD247
162	Abnormal erythrocyte sedimentation rate	C0438217	3	26	1.07039419477e-05	6.216423637759019e-05	IL2RB,IL2RA,CD247
163	IgA nephropathy, susceptibility to, 3	C0017661	13	650	1.07869792385e-05	6.254796623177284e-05	VAV3,BTK,HLA-E,FCGR3A,PIK3CB,LAT2,FCGR2A,JAK3,CD3G,FN1,TYROBP,IL2,PIK3CA
164	Chronic graft-versus-host disease	C0867389	5	93	1.09408955676e-05	6.293169608595549e-05	HLA-E,IL2RA,IGHV2-5,IL2,KLRK1
167	Morphologically altered structure	C1260954	3	27	1.25134307901e-05	6.408288564850346e-05	PIK3CB,FN1,PIK3CA
168	Steroid-sensitive nephrotic syndrome	C0403396	3	27	1.25134307901e-05	6.446661550268611e-05	PLCG2,HLA-E,IL2
169	Nephrotic syndrome, type 5, with or without ocular abnormalities	C0027726	8	263	1.26729048574e-05	6.485034535686876e-05	FCGR1A,IL2RG,FCGR3A,FCGR2A,IGHE,FN1,IL2,B2M
170	Leukemogenesis	C0598766	13	660	1.27933202742e-05	6.523407521105142e-05	IL2RG,SOS1,BTK,PIK3CB,IL2RA,FCGR2A,JAK3,JAK1,IGHV2-5,IL2,PIK3CA,SYK,RAC1
171	Constitutional symptom	C0009812	12	572	1.28829287213e-05	6.561780506523407e-05	PLCG2,IGHM,BTK,IL2RB,IL2RA,TYROBP,IL2,PIK3CA,CD247,PIK3R1,TREM2,B2M
172	Scleroderma	C0036421	12	573	1.31224224994e-05	6.600153491941672e-05	FCGR1A,SOS1,HLA-E,FCGR3A,PIK3CB,IL2RB,IL2RA,FN1,IL2,PIK3CA,CD247,GRAP2
173	Mastocytosis	C0024899	4	57	1.36506820115e-05	6.638526477359939e-05	PIK3CB,IL2RA,IGHE,PIK3CA
174	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C1961102	15	854	1.40068645869e-05	6.676899462778205e-05	BTK,HLA-E,PIK3CB,ELMO1,IL2RA,FCGR2A,JAK3,JAK1,IGHV2-5,IL2,PIK3CA,FYN,KLRK1,SYK,LCK
175	Malignant Glioma	C0555198	10	412	1.41578379717e-05	6.71527244819647e-05	SOS1,LAT,PIK3CB,ELMO1,PIK3CA,KLRK1,PIK3R2,PIK3R1,GRAP2,RAC1
176	Periodontal Attachment Loss	C0206114	3	28	1.45385396407e-05	6.753645433614736e-05	FCGR3A,FCGR2A,IL2
177	Abnormality of the immune system	C4021753	18	1164	1.4612194879e-05	6.792018419033001e-05	IL2RG,PLCG2,SOS1,IGHM,BTK,FCGR3A,IL2RB,IL2RA,JAK3,CD3G,TYROBP,PIK3CA,CD247,PIK3R1,TREM2,B2M,IGKC,LCK
178	Arthralgia	C0003862	6	149	1.60530924855e-05	6.830391404451267e-05	PLCG2,IL2RB,IL2RA,TYROBP,CD247,TREM2
185	Colitis, Ulcerative	C0009319	13	679	1.75328035982e-05	7.099002302379124e-05	PLCG2,BTK,PIK3CB,IL2RA,FCGR2A,JAK3,FN1,IL2,PIK3CA,PIK3R1,B2M,GRAP2,RAC1
186	Abnormality of fluid regulation	C2364164	9	346	1.7939540378e-05	7.137375287797391e-05	IL2RG,SOS1,IGHM,IL2RB,IL2RA,FN1,CD247,PIK3R1,B2M
187	Allergic disposition	C3539909	7	210	1.81209224552e-05	7.175748273215656e-05	HLA-E,IGHG2,IL2RA,FCGR2A,IGHE,IGHG3,IL2
188	Hormone receptor positive tumor	C1446409	4	61	1.90656414735e-05	7.214121258633922e-05	PIK3CB,IL2RA,PIK3CA,LYN
189	Elevated erythrocyte sedimentation rate	C0151632	3	30	1.92983597657e-05	7.252494244052188e-05	IL2RB,IL2RA,CD247
190	Verrucae	C0043037	3	30	1.92983597657e-05	7.290867229470454e-05	IGHM,PIK3CA,PIK3R1
191	Abnormality of immune system physiology	C4023616	15	884	2.13488297199e-05	7.329240214888719e-05	IL2RG,PLCG2,IGHM,BTK,FCGR3A,IL2RB,IL2RA,JAK3,CD3G,PIK3CA,CD247,PIK3R1,B2M,IGKC,LCK
192	Hereditary factor VIII deficiency disease	C0019069	5	105	2.19191744265e-05	7.367613200306984e-05	FCGR1A,HLA-E,IL2RA,FCGR2A,IL2
193	Abnormality of the conjunctiva	C4025847	5	105	2.19191744265e-05	7.40598618572525e-05	IGHM,BTK,PIK3CA,PIK3R1,B2M
194	Tuberculosis, Pulmonary	C0041327	7	218	2.36994667706e-05	7.444359171143516e-05	HLA-E,FCGR3A,IL2RA,FCGR2A,IL2,CD247,KLRK1
200	Abnormality of skin physiology	C4023527	8	286	2.45795817986e-05	7.674597083653108e-05	IL2RG,IGHM,BTK,IL2RA,CD3G,PIK3CA,PIK3R1,B2M
201	Decrease in T cell count	C0392756	3	32	2.51134774573e-05	7.712970069071373e-05	IL2RG,IL2RA,CD247
202	Vascular malformation, primary intraosseous	C0158570	3	32	2.51134774573e-05	7.75134305448964e-05	PIK3CA,LCP2,ELMO2
203	Histiocytic medullary reticulosis	C0019623	3	32	2.51134774573e-05	7.789716039907906e-05	IL2RG,HLA-E,IL2RA
204	 {Porphyria cutanea tarda, susceptibility to}, 176100 (3)	C0162566	3	32	2.51134774573e-05	7.828089025326171e-05	HLA-E,PIK3CB,PIK3CA
205	Apraxia	C0003635	5	108	2.57231553304e-05	7.866462010744436e-05	IL2RB,IL2RA,TYROBP,CD247,TREM2
206	Recurrent skin infections	C1853193	4	65	2.60213368947e-05	7.904834996162703e-05	IL2RG,IGHM,BTK,PIK3R1
207	Progressive Neoplastic Disease	C0677932	6	161	2.64641651946e-05	7.943207981580968e-05	FCGR3A,IGHV2-5,IL2,IGHV1-69,PIK3CA,CD247
208	Progressive cGVHD	C3539781	6	161	2.64641651946e-05	7.981580966999233e-05	FCGR3A,IGHV2-5,IL2,IGHV1-69,PIK3CA,CD247
239	Prostate Cancer, Hereditary, 7	C1853195	3	33	2.84590672547e-05	9.171143514965465e-05	SOS1,PIK3CB,PIK3CA
240	Periodontal Pocket	C0031094	3	33	2.84590672547e-05	9.20951650038373e-05	FCGR3A,FCGR2A,IL2
241	Herpes Simplex Infections	C0019348	11	529	2.86619640014e-05	9.247889485801995e-05	BTK,HLA-E,FCGR3A,LAT,PIK3CB,IGHG3,IGHG1,FN1,IL2,PIK3CA,KLRK1
242	Exanthema	C0015230	9	366	2.89623068761e-05	9.286262471220262e-05	IL2RG,IGHM,BTK,HLA-E,FN1,PIK3CA,PIK3R1,B2M,IGKC
243	Otitis media	C0029882	7	227	3.16304372537e-05	9.324635456638527e-05	FCGR1A,IL2RG,IGHM,BTK,FCGR3A,FCGR2A,PIK3R1
248	Primary immune deficiency disorder	C0398686	4	68	3.24202326352e-05	9.516500383729855e-05	IL2RG,BTK,HLA-E,JAK3
249	T-cell acute lymphoblastic leukemias	C1961099	9	371	3.24864665256e-05	9.55487336914812e-05	IL2RG,IGHM,PIK3CB,IL2RA,JAK3,JAK1,IL2,PIK3CA,LCK
250	Graves Disease	C0018213	9	374	3.47724182638e-05	9.593246354566386e-05	VAV3,HLA-E,FCGR3A,PIK3CB,IL2RA,FCGR2A,GRB2,IL2,PIK3CA
251	Abnormality of cells of the lymphoid lineage	C4023027	4	69	3.48037682321e-05	9.631619339984652e-05	IL2RG,IGHM,IL2RA,CD247
252	Sinusitis	C0037199	5	114	3.49231133917e-05	9.669992325402917e-05	IL2RG,IGHM,BTK,FCGR3A,PIK3R1
253	Leukopenia	C0023530	8	301	3.66354946204e-05	9.708365310821182e-05	FCGR1A,IL2RG,IGHM,BTK,FCGR3A,IL2RA,IL2,CD247
254	Hepatitis	C0019159	9	377	3.71947027495e-05	9.746738296239448e-05	SOS1,IGHM,BTK,HLA-E,IL2RA,IL2,PIK3CA,KLRK1,PIK3R1
255	Skin lesion	C0037284	4	70	3.73209025799e-05	9.785111281657713e-05	PIK3CB,FN1,IL2,PIK3CA
256	Tumor necrosis	C0333516	6	170	3.74804737282e-05	9.823484267075979e-05	HLA-E,FCGR3A,IL2RB,JAK1,IL2,SYK
257	Metastatic Carcinoma	C1384494	3	36	4.04607189209e-05	9.861857252494244e-05	PIK3CB,IL2,PIK3CA
261	Lupus Vulgaris	C0024131	8	307	4.26957165673e-05	0.00010015349194167305	HLA-E,FCGR3A,IL2RA,FCGR2A,IGHG3,IGHV2-5,IL2,CD247
262	Alveolar Bone Loss	C0002382	3	37	4.51774052489e-05	0.00010053722179585572	FCGR3A,FCGR2A,IL2
263	Noonan syndrome with multiple lentigines	C0175704	3	37	4.51774052489e-05	0.00010092095165003838	SOS1,PIK3CB,PIK3CA
264	latent infection	C0872054	4	73	4.57258738725e-05	0.00010130468150422103	HLA-E,LAT,PIK3CB,PIK3CA
265	Lymphoma, Follicular	C0024301	9	389	4.838344085e-05	0.00010168841135840369	FCGR1A,FCGR3A,PIK3CB,IL2RA,FCGR2A,IGHV2-5,PIK3CA,IGKV1-5,B2M
266	Pemphigus Vulgaris	C0030809	4	74	4.88299517163e-05	0.00010207214121258635	HLA-E,IGHG3,IL2,GRAP2
267	Abnormality of lung morphology	C4021760	12	651	4.92298039981e-05	0.000102455871066769	IL2RG,PLCG2,SOS1,IGHM,BTK,FCGR3A,IL2RA,JAK3,CD3G,PIK3CA,PIK3R1,LCK
268	Tuberculosis	C0041296	12	652	5.00042272322e-05	0.00010283960092095165	FCGR1A,HLA-E,FCGR3A,PIK3CB,IL2RB,IL2RA,GRB2,IL2,PIK3CA,CLEC4E,KLRK1,GRAP2
269	Synovial sarcoma	C0039101	6	178	5.02005354273e-05	0.0001032233307751343	SOS1,HLA-E,PIK3CB,PIK3CA,GRAP2,RAC1
270	Eczema	C0013595	10	474	5.08935396795e-05	0.00010360706062931697	HLA-E,IL2RB,IL2RA,IGHE,CD3G,JAK1,IGHV2-5,FN1,IL2,PIK3CA
271	Primary Myelofibrosis	C0001815	6	179	5.20131487791e-05	0.00010399079048349962	PIK3CB,FCGR2A,JAK3,JAK1,FN1,PIK3CA
272	Pleural Effusion, Malignant	C0080032	4	75	5.20944396531e-05	0.00010437452033768227	IL2RA,IL2,CD247,RAC1
280	Hepatitis, Autoimmune	C0241910	5	123	5.35016692759e-05	0.00010744435917114352	HLA-E,IL2RA,FCGR2A,IGHV2-5,IL2
281	Undifferentiated leukemia	C1378511	4	76	5.55249585772e-05	0.00010782808902532617	IL2RA,IGHE,FN1,KLRK1
282	Urticaria	C0042109	5	124	5.5977277963e-05	0.00010821181887950884	IL2RG,PLCG2,IL2RA,IGHE,SYK
283	Chronic Periodontitis	C0266929	6	182	5.77752005898e-05	0.00010859554873369149	FCGR1A,FCGR3A,IL2RA,FCGR2A,IGHG3,IL2
284	Spondylarthropathies	C0949691	4	77	5.9127457252e-05	0.00010897927858787414	HLA-E,FCGR3A,IL2,B2M
285	Red eye	C0235267	4	77	5.9127457252e-05	0.00010936300844205679	IGHM,BTK,PIK3R1,B2M
286	Vasculitis	C0042384	6	183	5.98080282738e-05	0.00010974673829623945	FCGR1A,HLA-E,IL2RA,FCGR2A,FN1,IL2
291	Lymphoid leukemia	C0023448	7	252	6.60825450772e-05	0.00011166538756715272	FCGR3A,IL2RA,GRB2,KLRK1,SYK,LYN,LCK
292	Alopecia Areata	C0002171	4	79	6.68715213114e-05	0.00011204911742133537	FCGR1A,HLA-E,IL2RA,IL2
293	Idiopathic crescentic glomerulonephritis	C0403416	3	41	6.81338437009e-05	0.00011243284727551804	FCGR3A,JAK3,FN1
294	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	C0334634	8	327	6.93833578107e-05	0.0001128165771297007	IGHV4-34,BTK,IGHD,PIK3CB,JAK3,IGHV2-5,PIK3CA,SYK
295	Fibrosarcoma	C0016057	7	254	6.98338442727e-05	0.00011320030698388336	HLA-E,PIK3CB,IL2RB,JAK1,FN1,IL2,PIK3CA
296	Behcet Syndrome	C0004943	9	407	7.04970218628e-05	0.000113584036838066	BTK,HLA-E,FCGR3A,IL2RA,FCGR2A,JAK1,IL2,KLRC2,KLRD1
297	Neutropenia	C0027947	7	255	7.17748593665e-05	0.00011396776669224866	FCGR1A,IGHM,BTK,FCGR3A,FCGR2A,JAK1,PIK3R1
298	Acute anterior uveitis	C0701807	3	42	7.49944367524e-05	0.00011435149654643132	HLA-E,IL2RA,IL2
299	Acute Undifferentiated Leukemia	C0280141	4	81	7.53749436109e-05	0.00011473522640061397	IL2RA,IGHE,FN1,KLRK1
300	Sarcoidosis	C0036202	7	257	7.57916208419e-05	0.00011511895625479662	PLCG1,HLA-E,FCGR3A,IL2RA,IGHG1,IL2,IGKC
301	Periodontitis	C0031099	8	331	7.6132575248e-05	0.00011550268610897928	FCGR1A,HLA-E,FCGR3A,IL2RA,FCGR2A,FN1,IL2,PIK3R1
302	Abnormal respiratory system morphology	C4022992	13	778	7.65582964057e-05	0.00011588641596316194	IL2RG,PLCG2,SOS1,IGHM,BTK,FCGR3A,IL2RA,JAK3,CD3G,PIK3CA,PIK3R1,TREM2,LCK
310	Anaphylactic shock NOS	C0002792	3	43	8.23443688639e-05	0.00011895625479662319	FCGR1A,FCGR2A,IGHE
336	 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	C0751688	5	134	8.61392905087e-05	0.00012893323100537221	PIK3CB,IL2,PIK3CA,KLRK1,PIK3R1
337	Thyroiditis	C0040147	5	134	8.61392905087e-05	0.00012931696085955488	IL2RG,PLCG2,HLA-E,IL2RA,PIK3CA
338	Anaplastic large cell lymphoma, ALK negative	C0206180	7	263	8.89783190476e-05	0.00012970069071373752	PIK3CB,IL2RA,JAK3,JAK1,IL2,PIK3CA,SYK
339	Papilloma	C0030354	6	196	9.20080312258e-05	0.00013008442056792018	IGHM,PIK3CB,IL2RA,PIK3CA,PIK3R1,RAC1
340	Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive	C0013575	5	136	9.3487524093e-05	0.00013046815042210285	SOS1,PIK3CB,PIK3CA,PIK3R1,RAC1
341	Verotoxigenic Escherichia coli gastrointestinal tract infection	C0009450	16	1111	9.46116577274e-05	0.0001308518802762855	FCGR1A,HLA-E,FCGR3A,IGHG2,IL2RB,IL2RA,FCGR2A,JAK1,FN1,IL2,PIK3CA,KLRK1,KLRC2,KLRD1,SYK,GRAP2
342	Immune dysfunction with T-cell inactivation due to calcium entry defect 1	C0021053	6	197	9.49772961402e-05	0.00013123561013046815	HLA-E,PIK3CB,IL2RA,IL2,PIK3CA,SYK
343	Chronic hepatitis	C0019189	6	197	9.49772961402e-05	0.0001316193399846508	HLA-E,FCGR3A,SHC1,FN1,IL2,B2M
348	Carcinoma breast stage IV	C0278488	8	342	9.76038402699e-05	0.0001335379892555641	SOS1,HLA-E,FCGR3A,PIK3CB,FN1,IL2,PIK3CA,GRAP2
349	Allergic asthma	C0155877	6	200	0.000104356759304	0.00013392171910974675	HLA-E,LAT,IL2RA,IGHE,IL2,SYK
350	Embryonal rhabdomyosarcoma	C0206656	4	87	0.0001059487635	0.0001343054489639294	SOS1,PIK3CB,PIK3CA,GRAP2
351	Mucocutaneous Lymph Node Syndrome	C0026691	6	201	0.00010764568578	0.00013468917881811205	FCGR1A,HLA-E,FCGR3A,IL2RA,FCGR2A,IGHV1-69
352	Recurrent bacterial infections	C1844383	4	88	0.000111852278827	0.0001350729086722947	IGHM,BTK,IL2RA,PIK3R1
353	Recurrent upper respiratory tract infections	C0581381	4	88	0.000111852278827	0.00013545663852647735	IL2RG,IGHM,FCGR3A,JAK3
354	Pilocytic Astrocytoma	C0334583	4	88	0.000111852278827	0.00013584036838066002	PIK3CB,FN1,TYROBP,PIK3CA
357	Sickle Cell Trait	C0037054	3	47	0.000117057826625	0.00013699155794320798	FCGR1A,FCGR2A,IGHG3
358	Brucellosis	C0006309	3	47	0.000117057826625	0.00013737528779739065	FCGR2A,IL2,IGKV1-5
359	Arthritis, Psoriatic	C0003872	6	204	0.000118021936074	0.00013775901765157328	HLA-E,FCGR3A,IL2RA,FCGR2A,IL2,KLRK1
360	Hashimoto thyroiditis	C0677607	5	142	0.000118568806208	0.00013814274750575595	VAV3,PLCG2,HLA-E,IL2RA,IL2
361	Celiac Disease	C0007570	9	436	0.000124048964618	0.00013852647735993861	HLA-E,FCGR3A,IL2RB,ELMO1,IL2RA,FCGR2A,CD3G,IL2,CD247
362	Conjunctivitis	C0009763	4	90	0.000124413724018	0.00013891020721412125	IGHM,BTK,PIK3R1,B2M
363	Abnormality of adipose tissue	C4021524	5	144	0.000128021866805	0.00013929393706830392	TYROBP,PIK3CA,PIK3R1,TREM2,LCK
364	Inflammatory disorder	C1290884	7	279	0.000133722131072	0.00013967766692248658	HLA-E,FCGR3A,IGHE,FN1,IL2,B2M,GRAP2
366	Rous Sarcoma	C0086942	3	49	0.000137904223374	0.00014044512663085188	PIK3CB,FN1,PIK3CA
367	Anti-Glomerular Basement Membrane Disease	C0403529	3	49	0.000137904223374	0.00014082885648503455	FCGR3A,FCGR2A,SYK
368	IgA deficiency	C0162538	3	49	0.000137904223374	0.00014121258633921719	PLCG2,HLA-E,IL2RA
369	Burkitt lymphoma	C0006413	6	210	0.00014121647545	0.00014159631619339985	PIK3CB,IGHV2-5,IL2,PIK3CA,PIK3R1,GRAP2
370	Squamous cell carcinoma of the head and neck	C1168401	13	825	0.000141581012285	0.0001419800460475825	SOS1,HLA-E,FCGR3A,LAT,PIK3CB,IL2RA,JAK1,FN1,IL2,PIK3CA,KLRK1,GRAP2,LCK
